Johnson & Johnson (JNJ)
SIX
216.10
+4.60 (+2.17%)
Closed
Oct 7, 2026
Day's Range
216.10216.10
52 wk Range
172.65225.60
Financial Statements - JNJ - Johnson & Johnson
Revenue
94.19B
Net Income
26.80BNet Margin 28.5%
EBITDA
35.16B
Free Cash Flow
19.31B
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 94.19B |
| Cost of Goods | 30.25B |
| Gross Profit | 63.93B |
 Operating Expense | - |
| Operating Income | 25.59B |
| Non-Operating Interest | - |
| Other Income Expense | 6.89B |
| Pre Tax Income | 32.58B |
| Income Tax | 5.77B |
| Net Income | 26.80B |
| EPS Basic | 11.131511 |
| EPS Diluted | 11.03 |
| Basic Shares Outstanding | 2.40B |
| Diluted Shares Outstanding | 2.40B |
| Ebit | 33.55B |
| Ebitda | 35.16B |
| Net Income Continuous Operations | 26.80B |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
